PND38 10-YEAR COST-EFFECTIVENESS ANALYSES OF FREMANEZUMAB...

PND38 10-YEAR COST-EFFECTIVENESS ANALYSES OF FREMANEZUMAB COMPARED TO ERENUMAB AS PREVENTIVE TREATMENT IN EPISODIC MIGRAINE FOR PATIENTS WITH INADEQUATE RESPONSE TO PRIOR PREVENTIVE TREATMENTS

Smolen, L., Cohen, J., Klein, T., Gandhi, S.K., Thompson, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.1808
Date:
November, 2019
File:
PDF, 319 KB
2019
Conversion to is in progress
Conversion to is failed